VOZUCA M 0.2 (Metformin (500mg) + Voglibose (0.2mg))

Vozuca-M Tablet is classified within anti-diabetic medications and serves as a combination treatment for managing type 2 diabetes in adults. Its primary purpose is to assist individuals in regulating their blood glucose levels. For optimal results, it is recommended that the tablet be ingested with food, taken consistently at the same time daily. The prescribing physician will determine the appropriate dosage, which may be adjusted based on the patient’s blood sugar readings and overall response to the treatment. Continuation of Vozuca-M is crucial even if the patient feels well or their glucose levels appear stable; discontinuation without medical advice can lead to elevated blood sugar levels and increase the risk for serious complications, including kidney damage, vision impairment, nerve issues, and potential limb loss. This medication is only one facet of a comprehensive diabetes management plan that should also incorporate a balanced diet, regular physical activity, and weight management as recommended by a healthcare professional. Lifestyle modifications play a critical role in effective diabetes control. Although generally well-tolerated, Vozuca-M may lead to side effects such as nausea, altered taste perception, reduced appetite, gas, abdominal discomfort, diarrhea, and skin rashes; these effects are often temporary and may resolve independently. If symptoms persist or become concerning, it is advisable to seek medical advice. Vozuca-M is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Prior to starting this medication, individuals with a history of heart disease should inform their healthcare provider. Pregnant or nursing individuals are encouraged to consult their physician before use. Regular monitoring of blood glucose levels, along with periodic assessments of blood cell counts and liver function, may be necessary during treatment.